Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP119138.RARFLr7GAalpDjVqnbUIXSpEA1CrgsgKnSBsMWDapAd10130_assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119138.RARFLr7GAalpDjVqnbUIXSpEA1CrgsgKnSBsMWDapAd10130_provenance.
• NP119058.RAsN_GBxqBPCGO788NHHwUW31ii_SBYSMB8LNbrXj14pM130_assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119058.RAsN_GBxqBPCGO788NHHwUW31ii_SBYSMB8LNbrXj14pM130_provenance.
• NP118527.RAck4xecl7GFWtzJVCKe1z-NgjdH1HkU3fr2d6rct_76E130_assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118527.RAck4xecl7GFWtzJVCKe1z-NgjdH1HkU3fr2d6rct_76E130_provenance.
• NP118879.RAG0aJMty1S1uxgATOa-3s5O_QtyQYvKs3huJDEmsagyw130_assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118879.RAG0aJMty1S1uxgATOa-3s5O_QtyQYvKs3huJDEmsagyw130_provenance.
• NP118518.RArB7y7BkhsiOfvrCxjGhuRjh2VydJWrqeV36aQUs5dx4130_assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118518.RArB7y7BkhsiOfvrCxjGhuRjh2VydJWrqeV36aQUs5dx4130_provenance.
• assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP182075.RASZJ22mYh66-PTH7Oxb8iy1hLqL9x0IYznmWecq9J5tU130_assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182075.RASZJ22mYh66-PTH7Oxb8iy1hLqL9x0IYznmWecq9J5tU130_provenance.
• NP182253.RATZWijqNUiBZ6OH_BuH12996TbdumcThNj_ahD7J0PiA130_assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182253.RATZWijqNUiBZ6OH_BuH12996TbdumcThNj_ahD7J0PiA130_provenance.
• NP182333.RAagYodojSrNAuVS2W0fEF4RmF6i2xD-N4LIpW7oevLt0130_assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182333.RAagYodojSrNAuVS2W0fEF4RmF6i2xD-N4LIpW7oevLt0130_provenance.
• assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP181715.RAr3_s4ZNuzWMeS4jCXkPNY8NR8meI4tzyM2EfuRshNqs130_assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181715.RAr3_s4ZNuzWMeS4jCXkPNY8NR8meI4tzyM2EfuRshNqs130_provenance.
• NP181724.RAs2pnRzuv31hp0EEG8RD8N9oDFhuqAXKOQuDQ6hWj1wQ130_assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181724.RAs2pnRzuv31hp0EEG8RD8N9oDFhuqAXKOQuDQ6hWj1wQ130_provenance.
• assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP233081.RAd21K-mlol_VbeAcRKJyxcszE92uKNQ_LZVMdqbwU-Ww130_assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP233081.RAd21K-mlol_VbeAcRKJyxcszE92uKNQ_LZVMdqbwU-Ww130_provenance.
• NP233084.RAfw1ixAcXw4W6qxazZ8jI8VFCQYea7VGw8dgWKns7GTk130_assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP233084.RAfw1ixAcXw4W6qxazZ8jI8VFCQYea7VGw8dgWKns7GTk130_provenance.
• NP233085.RAa_oNmsgxDsB3pnn33uWFnWFWgrlekqHSs7JnY-j8D6o130_assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP233085.RAa_oNmsgxDsB3pnn33uWFnWFWgrlekqHSs7JnY-j8D6o130_provenance.
• NP233082.RAA4vMEz4KTLJge0lj8nXqcteYKphjjAuL_ueJgPngCKQ130_assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP233082.RAA4vMEz4KTLJge0lj8nXqcteYKphjjAuL_ueJgPngCKQ130_provenance.
• NP233083.RADATyOtA39jjNw1QNFYgdhHlu-ukFAqxNc26gx03mqOw130_assertion description "[Measurement of Melan-A, gp100, MAGE-3, MIA and tyrosinase represents a prognostic factor and a method for early detection of metastasis and treatment response of melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP233083.RADATyOtA39jjNw1QNFYgdhHlu-ukFAqxNc26gx03mqOw130_provenance.